Bank of America Forecasts Strong Price Appreciation for GE HealthCare Technologies (NASDAQ:GEHC) Stock

GE HealthCare Technologies (NASDAQ:GEHC) had its price target increased by investment analysts at Bank of America from $82.00 to $92.00 in a research note issued on Monday,Benzinga reports. The firm currently has a “neutral” rating on the stock. Bank of America‘s price target would suggest a potential upside of 11.08% from the company’s previous close.

A number of other research analysts have also recently issued reports on GEHC. Weiss Ratings reissued a “hold (c+)” rating on shares of GE HealthCare Technologies in a research note on Monday, December 29th. Citigroup boosted their price objective on GE HealthCare Technologies from $83.00 to $88.00 and gave the company a “neutral” rating in a research report on Thursday, December 11th. Wall Street Zen downgraded shares of GE HealthCare Technologies from a “buy” rating to a “hold” rating in a report on Saturday, September 20th. Wells Fargo & Company cut their price target on shares of GE HealthCare Technologies from $89.00 to $87.00 and set an “overweight” rating on the stock in a research note on Thursday, October 30th. Finally, Jefferies Financial Group increased their price objective on shares of GE HealthCare Technologies from $95.00 to $105.00 and gave the stock a “buy” rating in a research report on Thursday, December 11th. Six research analysts have rated the stock with a Buy rating and seven have given a Hold rating to the company. According to data from MarketBeat.com, the stock presently has a consensus rating of “Hold” and a consensus price target of $87.50.

GE HealthCare Technologies Trading Up 1.0%

GEHC opened at $82.82 on Monday. The firm’s fifty day moving average is $79.34 and its two-hundred day moving average is $76.21. The firm has a market cap of $37.73 billion, a PE ratio of 17.11, a price-to-earnings-growth ratio of 3.20 and a beta of 1.08. GE HealthCare Technologies has a twelve month low of $57.65 and a twelve month high of $94.80. The company has a debt-to-equity ratio of 0.83, a quick ratio of 0.95 and a current ratio of 1.18.

GE HealthCare Technologies (NASDAQ:GEHC) last announced its quarterly earnings results on Wednesday, October 29th. The company reported $1.07 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.05 by $0.02. The company had revenue of $5.14 billion during the quarter, compared to analyst estimates of $5.07 billion. GE HealthCare Technologies had a net margin of 10.94% and a return on equity of 22.52%. The firm’s revenue was up 5.8% on a year-over-year basis. During the same quarter in the previous year, the business earned $1.14 EPS. GE HealthCare Technologies has set its FY 2025 guidance at 4.510-4.630 EPS. Equities research analysts anticipate that GE HealthCare Technologies will post 4.68 EPS for the current year.

Institutional Trading of GE HealthCare Technologies

A number of hedge funds and other institutional investors have recently made changes to their positions in the business. Allianz SE grew its position in GE HealthCare Technologies by 165.2% in the second quarter. Allianz SE now owns 350 shares of the company’s stock valued at $26,000 after purchasing an additional 218 shares in the last quarter. E Fund Management Hong Kong Co. Ltd. boosted its stake in shares of GE HealthCare Technologies by 130.7% during the 3rd quarter. E Fund Management Hong Kong Co. Ltd. now owns 346 shares of the company’s stock worth $26,000 after buying an additional 196 shares during the last quarter. Godsey & Gibb Inc. bought a new position in shares of GE HealthCare Technologies in the 3rd quarter valued at about $26,000. Oakworth Capital Inc. increased its position in shares of GE HealthCare Technologies by 1,876.2% in the third quarter. Oakworth Capital Inc. now owns 415 shares of the company’s stock valued at $31,000 after acquiring an additional 394 shares during the last quarter. Finally, Gladwyn Financial Advisors Inc. bought a new stake in GE HealthCare Technologies during the second quarter worth about $34,000. 82.06% of the stock is currently owned by institutional investors and hedge funds.

About GE HealthCare Technologies

GE HealthCare Technologies (NASDAQ: GEHC) is a global medical technology and diagnostics company that develops, manufactures and markets a broad range of products and services for healthcare providers. Its portfolio centers on diagnostic imaging systems, including MRI, CT, PET and X-ray modalities, as well as ultrasound equipment. The company also supplies patient monitoring and anesthesia delivery systems, interventional and surgical imaging solutions, and molecular imaging technologies used in both clinical care and research settings.

In addition to hardware, GE HealthCare offers software, analytics and lifecycle services aimed at improving clinical workflows and equipment uptime.